| 1. |
-
- 2019
-
Tidskriftsartikel (refereegranskat)
|
|
| 2. |
- Bäckhed, Fredrik, 1973, et al.
(författare)
-
Dynamics and Stabilization of the Human Gut Microbiome during the First Year of Life
- 2015
-
Ingår i: Cell Host & Microbe. - Cambridge : Elsevier BV. - 1931-3128 .- 1934-6069. ; 17:5, s. 690-703
-
Tidskriftsartikel (refereegranskat)abstract
- The gut microbiota is central to human health, but its establishment in early life has not been quantitatively and functionally examined. Applying metagenomic analysis on fecal samples from a large cohort of Swedish infants and their mothers, we characterized the gut microbiome during the first year of life and assessed the impact of mode of delivery and feeding on its establishment. In contrast to vaginally delivered infants, the gut microbiota of infants delivered by C-section showed significantly less resemblance to their mothers. Nutrition had a major impact on early microbiota composition and function, with cessation of breast-feeding, rather than introduction of solid food, being required for maturation into an adult-like microbiota. Microbiota composition and ecological network had distinctive features at each sampled stage, in accordance with functional maturation of the microbiome. Our findings establish a framework for understanding the interplay between the gut microbiome and the human body in early life.
|
|
| 3. |
- Chen, Zhipeng, et al.
(författare)
-
Design, Synthesis, and Structure-Activity Relationship of N-Aryl-N'-(thiophen-2-yl) thiourea Derivatives as Novel and Specific Human TLR1/2 Agonists for Potential Cancer Immunotherapy
- 2021
-
Ingår i: Journal of Medicinal Chemistry. - Washington, DC : American Chemical Society (ACS). - 0022-2623 .- 1520-4804. ; 64:11, s. 7371-7389
-
Tidskriftsartikel (refereegranskat)abstract
- The previous virtual screening of ten million compounds yielded two novel nonlipopeptide-like chemotypes as TLR2 agonists. Herein, we present the chemical optimization of our initial hit, 1-phenyl-3-(thiophen-2-yl) urea, which resulted in the identification of SMU-C80 (EC50 = 31.02 ± 1.01 nM) as a TLR2-specific agonist with a 370-fold improvement in bioactivity. Mechanistic studies revealed that SMU-C80, through TLR1/2, recruits the adaptor protein MyD88 and triggers the NF-κB pathway to release cytokines such as TNF-α and IL-1β from human, but not murine, cells. To the best of our knowledge, it is the first species-specific TLR1/2 agonist reported until now. Moreover, SMU-C80 increased the percentage of T, B, and NK cells ex vivo and activated the immune cells, which suppressed cancer cell growth in vitro. In summary, we obtained a highly efficient and specific human TLR1/2 agonist that acts through the MyD88 and NF-κB pathway, facilitating cytokine release and the simultaneous activation of immune cells that in turn affects the apoptosis of cancer cells. © 2021 American Chemical Society
|
|
| 4. |
- Vinel, Alexey, 1983-, et al.
(författare)
-
Performance Analysis of the Random Access in IEEE 802.16
- 2005
-
Ingår i: IEEE International Symposium on Personal, Indoor and Mobile Radio Communications, PIMRC. - New York, USA : IEEE Press. - 9783800729098 ; , s. 1596-1600
-
Konferensbidrag (refereegranskat)abstract
- Recently, the IEEE has standardized the 802.16 protocol for metropolitan broadband wireless access systems. According to the standard, therandom access scheme based on the slotted binary exponential backoff algorithm is used in this system for initial ranging and bandwidth requests transmission. This paper provides both the simulation and analytical models for the investigation of the random access in IEEE 802.16. Based on the assumption of finite number of subscriber stations and ideal channel conditions the delay is evaluated for varying number of transmission opportunities and different backoff window sizes. © 2005 IEEE.
|
|
